Reading time: 8 minutes In psychedelic therapy, two substances are drawing significant attention: ketamine and psilocybin (the active compound in “magic” mushrooms), both of which are considered psychedelic drugs. Both show promise in treating mental health conditions such as depression, anxiety, and trauma. Yet, they differ fundamentally in their mechanisms, effects, therapeutic use, and accessibility. These substances are among the





